Back to Janus Henderson Group Ltd. Janus Henderson Group Ltd.

TVTXTVTX
22 quarters

Position history for Janus Henderson Group Ltd.Janus Henderson Group Ltd.'s holdings in TRAVERE THERAPEUTICS INC

Yes. Janus Henderson holds 11,419,586 shares of TVTX (Travere Therapeutics), worth $339.2M, as of its Q1 2026 13F filing. It increased the position by 908,420 shares (+8.6%) from Q4 2025. Janus Henderson has held TVTX in every 13F on record since Q4 2020, 22 quarterly filings. TVTX is 0.2% of Janus Henderson's reported 13F portfolio.

Current Value

$339.2M

Current Shares

11.4M

Total Value Change

+$227.9M

Total Shares Change

+7.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
11.4M
+8.6%
$339.2M0.2%$29.71
40
2025-Q4
Decreased
10.5M
-0.8%
$401.7M0.2%$38.21
0
2025-Q3
Increased
10.6M
+11.1%
$253.3M0.1%$23.90
41
2025-Q2
Increased
9.5M
+26.7%
$141.2M0.1%$14.80
37
2025-Q1
Increased
7.5M
+85.5%
$148.1M0.1%$17.92
47
2024-Q4
Increased
4.1M
+127x
$70.7M0.0%$17.42
48
2024-Q3
Unchanged
31,813
0.0%
$444,5870.0%$13.99
0
2024-Q2
Decreased
31,813
-1.1%
$261,1850.0%$8.22
0
2024-Q1
Increased
32,181
0.0%
$247,7970.0%$7.71
23
2023-Q4
Decreased
32,180
-0.2%
$288,8210.0%$8.99
0
2023-Q3
Decreased
32,235
-99.5%
$288,3400.0%$8.94
0
2023-Q2
Increased
7M
+1.8%
$107M0.1%$15.36
30
2023-Q1
Increased
6.8M
+34.5%
$154M0.1%$22.49
47
2022-Q4
Increased
5.1M
+30.1%
$107.1M0.1%$21.03
38
2022-Q3
Decreased
3.9M
-3.1%
$96.4M0.1%$24.64
0
2022-Q2
Decreased
4M
-2.7%
$97.9M0.1%$24.23
0
2022-Q1
Increased
4.2M
+3.4%
$107M0.1%$25.77
31
2021-Q4
Decreased
4M
-0.2%
$124.7M0.1%$31.04
0
2021-Q3
Increased
4M
+3.0%
$97.6M0.0%$24.25
31
2021-Q2
Decreased
3.9M
-5.9%
$57M0.0%$14.59
0
2021-Q1
Increased
4.2M
+1.6%
$103.6M0.0%$24.97
30
2020-Q4
New
4.1M
-
$111.3M0.1%$27.26
42

Other major holders of TVTX: Jupiter Topco LLC, BlackRock, Inc., FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used